Retinoblastoma protein and the cell cycle.

Deregulation of the cell cycle may contribute one of the primary mechanisms through which cancer arises. Eukaryotic cell division has been found to be a strictly controlled process, involving response to both positive and negative external signals and assessment of the cell's internal state. Several recent discoveries have strengthened and refined the theory that the retinoblastoma protein is involved in the decision between cell division and differentiation, and have begun to provide an outline of the nature of this involvement.

[1]  R. Weinberg,et al.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins , 1992, Cell.

[2]  A. Rustgi,et al.  Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product , 1991, Nature.

[3]  Phang-lang Chen,et al.  Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation , 1989, Cell.

[4]  M. Botchan,et al.  The retinoblastoma gene product regulates Sp1-mediated transcription , 1992, Molecular and cellular biology.

[5]  Marc Vidal,et al.  A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F , 1992, Cell.

[6]  L. Donoso,et al.  DNA-binding activity of retinoblastoma protein is intrinsic to its carboxyl-terminal region. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[7]  Y. Taya,et al.  In vitro phosphorylation of the tumor suppressor gene RB protein by mitosis-specific histone H1 kinase. , 1989, Biochemical and biophysical research communications.

[8]  R. Eisenman,et al.  Myc and Max proteins possess distinct transcriptional activities , 1992, Nature.

[9]  Michael R. Green,et al.  Retinoblastoma gene product activates expression of the human TGF-β2 gene through transcription factor ATF-2 , 1992, Nature.

[10]  A. Bradley,et al.  Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis , 1992, Nature.

[11]  R. Weinmann,et al.  The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F , 1991, Cell.

[12]  Y. Qian,et al.  A retinoblastoma-binding protein related to a negative regulator of Ras in yeast , 1993, Nature.

[13]  W. Lee,et al.  RB protein as a cellular "corral" for growth-promoting proteins. , 1991, Cold Spring Harbor symposia on quantitative biology.

[14]  W. Lee,et al.  Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. , 1991, The EMBO journal.

[15]  C. Anderson,et al.  The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. , 1991, The EMBO journal.

[16]  Jonathan A. Cooper,et al.  RB and the cell cycle: Entrance or exit? , 1989, Cell.

[17]  K. Münger,et al.  Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor beta 1 and by the retinoblastoma gene product. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Y. Chen,et al.  Stability of retinoblastoma gene expression determines the tumorigenicity of reconstituted retinoblastoma cells. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[19]  E. Moran,et al.  E1A induces phosphorylation of the retinoblastoma protein independently of direct physical association between the E1A and retinoblastoma products , 1991, Molecular and cellular biology.

[20]  R. Weinberg,et al.  G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment , 1991, Cell.

[21]  A. Berns,et al.  Requirement for a functional Rb-1 gene in murine development , 1992, Nature.

[22]  P. L. Chen,et al.  Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. , 1988, Science.

[23]  N. L. Thangue,et al.  Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor , 1991, Nature.

[24]  W. Lee,et al.  Molecular genetics of the retinoblastoma suppressor gene. , 1991, Critical reviews in oncogenesis.

[25]  M. Ewen,et al.  The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner , 1992, Cell.

[26]  A. Pardee G1 events and regulation of cell proliferation. , 1989, Science.

[27]  R. Weinberg,et al.  Effects of an Rb mutation in the mouse , 1992, Nature.

[28]  S. Weintraub,et al.  Retinoblastoma protein switches the E2F site from positive to negative element , 1992, Nature.

[29]  J. Azizkhan,et al.  Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo , 1989, Molecular and cellular biology.

[30]  J. Nevins,et al.  Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Nevins,et al.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. , 1992, Science.

[32]  L. Tsai,et al.  A family of human cdc2‐related protein kinases. , 1992, The EMBO journal.

[33]  J. Nevins,et al.  The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. , 1992, Genes & development.

[34]  Wen-Hwa Lee,et al.  Abrogation by c-myc of Gl phase arrest induced by RB protein but not by p53 , 1992, Nature.

[35]  P. Robbins,et al.  Negative regulation of human c-fos expression by thes retinoblastoma gene product , 1990, Nature.

[36]  Pearl S Huang,et al.  Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product , 1991, Nature.

[37]  J. Nevins,et al.  A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex , 1992, Cell.

[38]  Y. Qian,et al.  The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle , 1991, Cell.

[39]  Peggy J. Farnham,et al.  Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties , 1992, Cell.

[40]  F. Hall,et al.  Co-purification of p34cdc2/p58cyclin A proline-directed protein kinase and the retinoblastoma tumor susceptibility gene product: interaction of an oncogenic serine/threonine protein kinase with a tumor-suppressor protein. , 1992, Oncogene.

[41]  Lee Wh,et al.  The molecular genetics of retinoblastoma. , 1990 .

[42]  Steven K. Hanks,et al.  Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins , 1992, Cell.

[43]  E. Y. Lee,et al.  A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product , 1991, Nature.

[44]  W. Lee,et al.  Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F , 1992, Molecular and cellular biology.

[45]  M. Sporn,et al.  Regulation of transforming growth factor beta 1 gene expression by the product of the retinoblastoma-susceptibility gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[46]  L. Tsai,et al.  Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F , 1992, Nature.

[47]  J. Massagué,et al.  Early gene responses to transforming growth factor-beta in cells lacking growth-suppressive RB function , 1991, Molecular and cellular biology.

[48]  D. Templeton Nuclear binding of purified retinoblastoma gene product is determined by cell cycle-regulated phosphorylation , 1992, Molecular and cellular biology.

[49]  E. Harlow,et al.  The retinoblastoma protein physically associates with the human cdc2 kinase , 1992, Molecular and cellular biology.

[50]  F. Kaye,et al.  Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product , 1991, Cell.

[51]  J. Massagué,et al.  Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation , 1990, Cell.

[52]  D. Livingston,et al.  The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[53]  W. Kaelin,et al.  The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein , 1991, Cell.